BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseLong noncoding RNAs and Alzheimer's diseaseFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsBody fluid biomarkers in Alzheimer's diseaseDifferential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Aβ deposition and learning and memory in mouse models of Alzheimer's diseaseLong Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury.Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's diseaseβ-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob diseaseCognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseFluid biomarkers in Alzheimer's disease - current conceptsThe Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.CSF Presenilin-1 complexes are increased in Alzheimer's diseaseCerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease.Regulation of α-secretase ADAM10 expression and activity.Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.The wide genetic landscape of clinical frontotemporal dementia: systematic combined sequencing of 121 consecutive subjects.Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease.Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study
P2860
Q22252572-BF378A88-C234-427E-BAB3-3D39B5607841Q26740231-C2A1F99B-59CD-4FC7-9AE2-E5F883F21397Q26784569-1991F804-1B56-465B-AFFB-9B94A0E2FD67Q26830098-4E316094-0F14-46AC-9DEE-751AF76F3961Q27323892-3F0AE910-1FFA-4443-B573-7726F9B1826AQ33624404-E5160BF7-9F21-4992-9F84-9ED3AFC0B0E8Q33686357-8AFBA5D7-3ED4-4F05-85B8-3A627C07C8F2Q34268487-7F25CEE5-3FDC-4B7D-88B1-AE0EEA38386CQ34405864-E3679578-B203-48EA-82AE-2980AF40A368Q34661859-E80C93C7-3F7F-47E6-AF11-62A39F5AA873Q34824216-DD111BBA-C435-4B16-9B96-68DEA5FF39C9Q35750755-C1871409-D799-4B0E-8AD1-07AADAE1F603Q36337525-D853AB41-F436-44D2-B4DF-FCCFCD7E75A8Q36953503-ED2C8EF1-DE6F-46BF-84F8-4B7BED106556Q37169136-AB12C25F-17AA-4F30-8667-E1626418289FQ37350716-7BEAA2A1-C733-473A-AC1D-FE94A501B6A6Q37485864-73EDDA3B-D0E6-4CFB-B603-4BDAF67A1844Q37524486-8BA6FF26-A4AE-4DB1-8547-48A6C2259B75Q37664735-7B5C8827-D9B5-49FF-9035-423249C1EECAQ37921309-7B14A2E9-A27B-4368-BA64-6A385F1EE8E2Q37942089-0139DA07-D200-4FBD-84F2-E7E2944A46F3Q47761998-81371C28-98A1-4722-B398-B0A6DA675596Q48177216-AC4F91F3-FCCE-4B2B-833A-79919C4E8FE3Q49172097-DEEAFC02-BE47-4C51-A41A-E68620BA6A0DQ53332958-D6B480E7-575B-4752-B2C6-C0DF4D7DB5ADQ58716141-513A797C-B945-4C67-A6FB-273AD5E24B99
P2860
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@en
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@nl
type
label
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@en
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@nl
prefLabel
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@en
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@nl
P2093
P50
P356
P1476
BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
@en
P2093
C Erik Hack
Cees Mulder
Jan H Verheijen
Robert Veerhuis
Sandra D Mulder
P304
P356
10.3233/JAD-2010-1367
P577
2010-01-01T00:00:00Z